Open access publisher BioMed Central, UK, and the Society for Immunotherapy of Cancer (SITC) have announced the launch of the Journal for ImmunoTherapy of Cancer (JITC). JITC is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.
As the official journal of SITC, JITC will be the cancer immunotherapy community's prime forum to discuss the critical issues in tumor immunology and cancer immunotherapy research, with an audience of the most influential names in the field. The journal is overseen by Editor-in-Chief Pedro Romero, as well as an Editorial Board of outstanding leaders in both basic and clinical tumor immunology and cancer immunotherapy fields.
SITC members will also receive waived article processing charges for manuscripts published in the journal during 2013.
